Abstract

Immunotherapy for hay fever due to ragweed, grass, birch, and mountain cedar pollens and for asthma due to ragweed, grass, house dust mite, and cat dander allergens relieves symptoms in controlled studies. Clinical improvement is specific for the allergen employed, depends on the dose administered, and may relapse six months to a year after injections are stopped. Immunological changes include a rise in IgG antibodies, an early rise and later decline in IgE antibodies, sometimes a rise in secretional antibodies, reduced basophil reactivity and sensitivity, and reduced lymphocyte responsiveness to allergens.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.